GRDX Stock Chart & Stats
$3.20
-$0.62(-16.23%)
―
--
Day’s Range― - ―
52-Week Range$1.08 - $6.93
Previous CloseN/A
VolumeN/A
Average Volume (3M)135.40K
Market Cap
$26.41M
Enterprise Value$18.85M
Total Cash (Recent Filing)$385.54K
Total Debt (Recent Filing)$2.59M
Price to Earnings (P/E)―
Beta1.05
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.70
Shares Outstanding6,913,241
10 Day Avg. Volume114,755
30 Day Avg. Volume135,398
Financial Highlights & Ratios
PEG Ratio-0.16
Price to Book (P/B)0.32
Price to Sales (P/S)207.82
P/FCF Ratio-1.32
Enterprise Value/Market Cap0.71
Enterprise Value/Revenue253.13
Enterprise Value/Gross Profit-32.64
Enterprise Value/Ebitda-2.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-5.22
Revenue Forecast (FY)$22.27M
GridAI Technologies News
GRDX FAQ
What was Gridai Technologies Corp.’s price range in the past 12 months?
Gridai Technologies Corp. lowest stock price was $1.08 and its highest was $6.93 in the past 12 months.
What is Gridai Technologies Corp.’s market cap?
Gridai Technologies Corp.’s market cap is $26.41M.
When is Gridai Technologies Corp.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Gridai Technologies Corp.’s earnings last quarter?
Currently, no data Available
Is Gridai Technologies Corp. overvalued?
According to Wall Street analysts Gridai Technologies Corp.’s price is currently Undervalued.
Does Gridai Technologies Corp. pay dividends?
Gridai Technologies Corp. does not currently pay dividends.
What is Gridai Technologies Corp.’s EPS estimate?
Gridai Technologies Corp.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Gridai Technologies Corp. have?
Gridai Technologies Corp. has 6,913,241 shares outstanding.
What happened to Gridai Technologies Corp.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Gridai Technologies Corp.?
Currently, no hedge funds are holding shares in GRDX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Gridai Technologies Corp.
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Ownership Overview
11.36% Insiders
0.54% Mutual Funds
1.10% Other Institutional Investors
85.89% Public Companies and
Individual Investors